The FDA has provided a series of important advice to patients when using a quinolone group as an “antibiotic” to protect once morest complications.
The FDA said preparations containing the “antibiotic” quinolone group should not be used if the patient had a history of tendon problems such as tendinitis or tendon rupture.
And the drug authority added: Before taking these preparations, the health care provider must be informed if the patient suffers from heart problems or diseases.
And she continued: If the patient has diabetes, you should carefully monitor blood glucose levels, and the Egyptian Medicines Authority advised once morest exposure to the sun during the followingnoon; This is because during the period of treatment with medicines, the patient is sensitive to sunlight, and it can cause facial and skin burns and damage the eyes.
